| Complex immune dysregulation in COVID-19 patients with severe respiratory failure EJ Giamarellos-Bourboulis, MG Netea, N Rovina, K Akinosoglou, ... Cell host & microbe 27 (6), 992-1000. e3, 2020 | 2116 | 2020 |
| Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline AJ Ullmann, JM Aguado, S Arikan-Akdagli, DW Denning, AH Groll, ... Clinical Microbiology and Infection 24, e1-e38, 2018 | 1263 | 2018 |
| DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? JA Roberts, SK Paul, M Akova, M Bassetti, JJ De Waele, G Dimopoulos, ... Clinical infectious diseases 58 (8), 1072-1083, 2014 | 1048 | 2014 |
| Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management DW Denning, J Cadranel, C Beigelman-Aubry, F Ader, A Chakrabarti, ... European Respiratory Journal 47 (1), 45-68, 2016 | 815 | 2016 |
| A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients SI Blot, FS Taccone, AM Van den Abeele, P Bulpa, W Meersseman, ... American journal of respiratory and critical care medicine 186 (1), 56-64, 2012 | 599 | 2012 |
| Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper# MH Abdul-Aziz, JWC Alffenaar, M Bassetti, H Bracht, G Dimopoulos, ... Intensive care medicine 46, 1127-1153, 2020 | 584 | 2020 |
| Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes FS Taccone, AM Van den Abeele, P Bulpa, B Misset, W Meersseman, ... Critical Care 19, 1-15, 2015 | 385 | 2015 |
| Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing … K Pontikis, I Karaiskos, S Bastani, G Dimopoulos, M Kalogirou, M Katsiari, ... International journal of antimicrobial agents 43 (1), 52-59, 2014 | 285 | 2014 |
| Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome G Dimopoulos, F Ntziora, G Rachiotis, A Armaganidis, ME Falagas Anesthesia & Analgesia 106 (2), 523-529, 2008 | 283 | 2008 |
| Impact of patient position on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials VG Alexiou, V Ierodiakonou, G Dimopoulos, ME Falagas Journal of critical care 24 (4), 515-522, 2009 | 279 | 2009 |
| Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients L Pagano, M Akova, G Dimopoulos, R Herbrecht, L Drgona, N Blijlevens Journal of Antimicrobial Chemotherapy 66 (suppl_1), i5-i14, 2011 | 277 | 2011 |
| Favorable anakinra responses in severe Covid-19 patients with secondary hemophagocytic lymphohistiocytosis G Dimopoulos, Q de Mast, N Markou, M Theodorakopoulou, A Komnos, ... Cell host & microbe 28 (1), 117-123. e1, 2020 | 251 | 2020 |
| Prevalence, risk factors, and mortality for ventilator-associated pneumonia in middle-aged, old, and very old critically ill patients S Blot, D Koulenti, G Dimopoulos, C Martin, A Komnos, WA Krueger, ... Critical care medicine 42 (3), 601-609, 2014 | 240 | 2014 |
| Invasive fungal infections in the ICU: how to approach, how to treat E Paramythiotou, F Frantzeskaki, A Flevari, A Armaganidis, G Dimopoulos Molecules 19 (1), 1085-1119, 2014 | 235 | 2014 |
| A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality M Bassetti, E Righi, F Ansaldi, M Merelli, C Scarparo, M Antonelli, ... Intensive care medicine 41, 1601-1610, 2015 | 222 | 2015 |
| Short-versus long-course antibacterial therapy for community-acquired pneumonia: a meta-analysis G Dimopoulos, DK Matthaiou, DE Karageorgopoulos, AP Grammatikos, ... Drugs 68, 1841-1854, 2008 | 222 | 2008 |
| Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the … M Hoenigl, J Salmanton-García, TJ Walsh, M Nucci, CF Neoh, JD Jenks, ... The Lancet Infectious Diseases 21 (8), e246-e257, 2021 | 213 | 2021 |
| Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature ME Falagas, AC Kastoris, EK Vouloumanou, PI Rafailidis, AM Kapaskelis, ... Future microbiology 4 (9), 1103-1109, 2009 | 207 | 2009 |
| Centers for Disease Control and Prevention guidelines for preventing central venous catheter-related infection: results of a knowledge test among 3405 European intensive care … SO Labeau, DM Vandijck, J Rello, S Adam, A Rosa, C Wenisch, ... Critical care medicine 37 (1), 320-323, 2009 | 200 | 2009 |
| Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy A Perner, AC Gordon, D De Backer, G Dimopoulos, JA Russell, J Lipman, ... Intensive care medicine 42, 1958-1969, 2016 | 197 | 2016 |
Matthew FalagasAlfa Institute Biomedical Sciences & Hygeia Hospital, Greece & Tufts Univ. Sch. Medicine, Boston, MAaibs.gr üzerinde doğrulanmış e-posta adresine sahip
